 |
Basic Introduction
Since MEP421 was first publicized, it has attracted many investors and franchises. The first country to seek international cooperation for the MEP421 patent was America, followed by Canada and Hong Kong. Currently various European countries and Australia are also applying for a patent. In China, over thirty medical groups and enterprises wish to make cooperative agreements. MEP421 is a popular product because it has such varied uses, since it is a curing as well as preventative medicine. Because of this, the future is full of opportunities for the use of MEP421.
|
